Novel immunoblot assay using four recombinant antigens for diagnosis of Epstein-Barr virus primary infection and reactivation
- PMID: 10405428
- PMCID: PMC85323
- DOI: 10.1128/JCM.37.8.2709-2714.1999
Novel immunoblot assay using four recombinant antigens for diagnosis of Epstein-Barr virus primary infection and reactivation
Abstract
A new immunoblot assay, composed of four Epstein-Barr virus (EBV)-encoded recombinant proteins (virus capsid antigen [VCA] p23, early antigen [EA] p138, EA p54, and EBNA-1 p72), was compared with an immunofluorescence assay on a total of 291 sera. The test was accurate in 94.5% of cases of primary EBV infection, while an immunoglobulin G anti-VCA p23 band with strong intensity correlated with reactivation.
Figures
References
-
- Debyser Z, Reynders M, Goubau P, Desmyter J. Comparative evaluation of three ELISA techniques and an indirect immunofluorescence assay for the serological diagnosis of Epstein-Barr virus infection. Clin Diagn Virol. 1997;8:71–81. - PubMed
-
- Färber I, Wutzler P, Wohlrabe P, Wolf H, Hinderer W, Sonneborn H-H. Serological diagnosis of infectious mononucleosis using three anti-Epstein-Barr virus recombinant ELISAs. J Virol Methods. 1993;42:301–308. - PubMed
-
- Fleisher G, Lennette E T, Henle G, Henle W. Incidence of heterophil antibody responses in children with infectious mononucleosis. J Pediatr. 1979;94:723–728. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
